Flunitrazolam

Flunitrazolam is a benzodiazepine derivative that has been sold online as a designer drug, and is a potent hypnotic and sedative drug similar to related compounds such as flunitrazepam, clonazolam and flubromazolam. It was first definitively identified and reported to the EMCDDA Early Warning System, by an analytical laboratory in Germany in October 2016,[1] and had not been described in the scientific or patent literature before this.[2]

Flunitrazolam
Legal status
Legal status
Identifiers
ChemSpider
Chemical and physical data
FormulaC17H12FN5O2
Molar mass337.307 g·mol−1
3D model (JSmol)

See also

References
  1. Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA
  2. Cornett EM, Novitch MB, Brunk AJ, Davidson KS, Menard BL, Urman RD, Kaye AD (June 2018). "New benzodiazepines for sedation". Best Practice & Research. Clinical Anaesthesiology. 32 (2): 149–164. doi:10.1016/j.bpa.2018.06.007. PMID 30322456.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.